Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Medley

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
IL-22 induces an acute-phase responseSpencer C Liang, Cheryl Nickerson-Nutter, Debra D Pittman, et al.
Acta Cytologica|January 1, 1996
Computer-assisted quality assuranceG L Wied, P H Bartels, M Bibbo, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
IL-22 induces an acute-phase responseSpencer C Liang, Cheryl Nickerson-Nutter, Debra D Pittman, et al.
Acta Cytologica|January 1, 1996
Computer-assisted quality assuranceG L Wied, P H Bartels, M Bibbo, et al.
The Biochemical Journal|March 6, 2014
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitorsSeungil Han, Robert M Czerwinski, Nicole L Caspers, et al.
Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.
Pageof 10